Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - SHORT-TERM INVESTMENTS
Short-term Investments ANAB - AnaptysBio, Inc.
355 M
LAST VALUE
160.34%
2 YEAR CAGR
2.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR